Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50 Day Moving Average – Should You Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR)’s share price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$14.60 and traded as high as C$15.03. Cipher Pharmaceuticals shares last traded at C$14.80, with a volume of 23,304 shares traded.

Cipher Pharmaceuticals Price Performance

The stock’s 50 day moving average is C$14.60 and its two-hundred day moving average is C$14.07. The stock has a market capitalization of C$375.48 million, a PE ratio of 22.09 and a beta of 0.89. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67.

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) last issued its quarterly earnings results on Thursday, November 6th. The company reported C$0.21 earnings per share (EPS) for the quarter. Cipher Pharmaceuticals had a net margin of 59.92% and a return on equity of 17.93%. The company had revenue of C$17.87 million during the quarter. As a group, sell-side analysts forecast that Cipher Pharmaceuticals Inc. will post 1.2907348 earnings per share for the current fiscal year.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.